The ideal reperfusion strategy for the ST-segment elevation myocardial infarction patient with expected delay to percutaneous coronary intervention: paradise lost or paradise renamed?

JACC Cardiovasc Interv. 2009 Oct;2(10):931-3. doi: 10.1016/j.jcin.2009.08.012.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angioplasty, Balloon, Coronary* / adverse effects
  • Angioplasty, Balloon, Coronary* / mortality
  • Combined Modality Therapy
  • Evidence-Based Medicine
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Health Services Accessibility*
  • Humans
  • Myocardial Infarction / mortality
  • Myocardial Infarction / therapy*
  • Patient Transfer
  • Platelet Aggregation Inhibitors / therapeutic use
  • Thrombolytic Therapy* / adverse effects
  • Thrombolytic Therapy* / mortality
  • Time Factors
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors